PharmTech LCGC Sciex Webinar 11.10
|Articles|October 1, 2009

Agilent Technologies Separates Bioanalytical Business into Two Groups

Agilent Technologies (Santa Clara, California) announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences.

Agilent Technologies (Santa Clara, California) announced the separation of its Life Science and Chemical Analysis Group into two businesses, Chemical Analysis and Life Sciences. Mike McMullen has been promoted to senior vice president of Agilent and to president of the Chemical Analysis Group, and Nick Roelofs has been promoted to senior vice president of Agilent and to president of the Life Sciences Group. According to Bill Sullivan, Agilent president and CEO, “The decision to create two separate businesses within bioanalytical measurement reflects the need to serve distinct sets of customers, along with Agilent’s commitment to building a stronger presence in bioanalytical markets.” Effective November 1, 2009, Agilent will comprise three separate business groups: Electronic Measurement, Chemical Analysis, and Life Sciences.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.